Ephedra Ban Effective In April; FDA Will Follow-Up On Internet Firms
This article was originally published in The Tan Sheet
Executive Summary
A 1final rule prohibiting the sale of dietary supplements containing ephedrine alkaloids will become effective April 12, FDA announced Feb. 6
You may also be interested in...
Ephedra Imports Legal While Nutraceutical Appeal Underway – Emord
FDA's refusal to allow Hong Kong-based broker EMAX to import ephedra-containing dietary supplements into the U.S. violates an April 2005 court ruling which invalidated the agency's ban on the botanical, according to a lawsuit filed April 21 by the firm Emord & Associates
Ephedra seizure
More than 2 mil. capsules of Asia MedLabs' ephedra-containing Vitera-XT were seized from the firm's facility in Houston by U.S. Marshals, FDA announces Nov. 23. Vitera-XT, a "traditional Asian formulation," lists ephedrine alkaloids among its ingredients and carries claims such as "treat[s]...persistent flu, fevers and [may be used] for protein release." The complaint the ingredients and claims render the product an "unapproved new and misbranded drug." FDA's final rule banning the botanical was published in February (1"The Tan Sheet" Feb. 9, 2004, p. 10)...
AHPA Modifies Ephedra Petition To Specify Two Chinese Herbals
The American Herbal Products Association is modifying a petition to stay FDA's ephedra ban by highlighting two Chinese herbal ingredients that the group feels are wrongly included